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Purpose: The aim of this study was to assess the role of pre-operative chest computed tomography (CT) compared with ab-
dominopelvic CT (AP-CT) and chest radiography (CXR) for detecting pulmonary metastasis in patients with primary color-
ectal cancer (CRC). Methods: We retrospectively analyzed the data of 619 patients with primary CRC who simultaneously re-
ceived a preoperative chest CT (chest CT group), AP-CT with hilar extension, and CXR (CXR group). Results: In the chest CT 
group, there were 297 (48.0%) normal, 198 (32%) benign, 96 (15.5%) indeterminate, 26 (4.2%) metastasis, and two lung 
cancers. Eighteen patients (2.9%) in the CXR group who had no pulmonary metastasis were diagnosed with pulmonary 
metastasis on a chest CT. The sensitivity and accuracy were 83.9% and 99.0% in the chest CT group, respectively, and 29.0% 
and 91.5% in the CXR group, respectively (P ＜  0.0001 and P = 0.0003). Conclusion: Chest CT appears to improve the accuracy 
of pre-operative staging in patients with CRC and is useful for the early detection of pulmonary metastasis as a baseline 
study for abnormal lung nodules.
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INTRODUCTION
 The lung is the second most common distant metastatic 
site for primary colorectal cancer (CRC), and about 10% of 
all patients with CRC develop pulmonary metastasis [1]. 
However, fewer than 10% of the patients are candidates 
for pulmonary metastasectomy [2]. Since Blalock [3] first 
reported the successful surgical resection of a pulmonary 
metastasis from colorectal cancer in 1994, and Thomford et 
al. reported the principles of pulmonary metastasis surgi-
cal resection, the procedure has been gradually accepted 
as a treatment for pulmonary metastasis and many physi-
cians have reported the value of surgical resection for pul-
monary metastases [4-6].
Traditionally, pulmonary staging for CRC has been con-
ducted by chest radiography (CXR), but CXR has low sen-
sitivity and specificity. According to the National Compre-
hensive Cancer Network (NCCN) guidelines v. 1. 2007, Yong Kwon Cho, et al.
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Fig. 1. Classification of the radiologic findings. (A) Normal. (B) Benign. (C) Metastatic. (D) Indeterminate.
chest computed tomography (CT) is recommended in-
stead of CXR for the pre-operative workup of CRC pa-
tients [7,8]. Although a chest CT scan is more sensitive 
than CXR for the detection of pulmonary metastases, not 
all lesions observed on a chest CT of patients with CRC 
will be metastases [9]. Another study reported that CXR 
was no more useful for detecting early pulmonary meta-
stases after curative colorectal surgery for stage III CRC 
than chest CT or abdominal CT [10].
We investigated the role of pre-operative chest CT com-
pared with abdominopelvic CT (AP-CT) with hilar ex-
tension and CXR, which was the previous standard meth-
od for detecting pulmonary metastasis in patients with 
primary CRC.
METHODS
Between January and June 2008, 767 consecutive pa-
tients who were diagnosed with CRC at Samsung Medical 
Center, Seoul, Korea were simultaneously checked pre-
operatively with CXR, AP-CT with hilar extension (CXR 
group), and chest CT (chest CT group). The upper limit of 
hilar extension was set at 3 cm above the highest point of 
the diaphragm. Chest CTs and CXRs were reviewed by a 
radiologist in the chest division, and the AP-CTs were re-
viewed by radiologists in the abdominal division. 
According to the radiologic findings, we divided the pa-
tients into four categories: normal, benign, metastatic, and 
indeterminate [11,12]. A pulmonary metastasis was de-
fined as a nodule that had spiculation, infiltration, or a mo-
nogonal shape and was ≥5 mm in size. An indeterminate 
nodule was defined as a nodule that had no calcification Routine chest CT as a preoperative work-up for primary colorectal cancer
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Fig. 2. Characteristics of the chest 
computed tomography (CT) group. 
F/U, follow-up.
 a)Thymoma (1), 
thyroid ca (1). 
b)Size ＜5 mm, with-
out calcification.
Fig. 3. Characteristics of the chest 
radiography (CXR) group. AP-CT, 
abdominopelvic-computed tomo-
graphy.
and was ＜5 mm in size (Fig. 1). Patients who had benign 
or indeterminate nodules had a follow-up chest CT within 
3 months, and all patients were routinely checked 6 
months later. Exclusion criteria were: 1) unknown results 
of the preoperative chest CT; 2) less than a 6-month fol-
low-up duration.
A total of 619 patients were included in this study, and 
we retrospectively analyzed the collected data. Three- 
hundred seventy-three of the patients were male (60.3%), 
and 246 were female (39.7%), with a mean age of 59.4 ± 11.6 
years (range, 23 to 88 years).
The McNemar test and Bennett’s method were used to 
compare the sensitivity, specificity, predictive value, and 
accuracy between the chest CT group and CXR group. A P- 
value ＜  0.05 was considered statistically significant.
RESULTS
Three-hundred twenty-two (52.0%) out of 619 patients 
showed radiologic abnormality on their chest CT. Among 
these patients, the lesions of 198 patients (32.0%) were di-
agnosed as benign nodules, 96 patients (15.5%) as in-
determinate nodules, 26 patients (4.2%) as pulmonary 
metastases, and two patients (0.3%) as lung cancer on 
chest CTs (Fig. 2). In the CXR group, 135 patients (21.8%) 
showed radiologic abnormality and, among them, the le-
sions of 75 patients (12.1%) were diagnosed as benign nod-
ules, the lesions of 50 patients (8.1%) were diagnosed as in-
determinate nodules, and the lesions of 8 patients (1.3%) 
were diagnosed as pulmonary metastases; 2 patients 
(0.3%) were diagnosed with lung cancer (Fig. 3). Twelve 
patients (1.9%) were diagnosed with no active pulmonary 
lesion, one patient (0.2%) with benign nodules, and three 
patients (0.5%) with indeterminate nodules; two patients 
(0.3%) who were diagnosed with lung cancer in the CXR 
group were diagnosed with pulmonary metastases on 
chest CT (Table 1). Fourteen of the 26 patients who had 
pulmonary metastases on the pre-operative chest CT had 
their diagnosis confirmed by video-assisted thoracoscopic 
resection and 12 of the 26 were routinely followed-up with 
chemotherapy and/or radiotherapy (Fig. 4). Eighteen Yong Kwon Cho, et al.
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Table 1. Pattern of the lung lesions according to preoperative diagnostic methods
Chest CT
NALL Benign Indeterminate Metastasis Lung cancer  Total
CXR with AP-CT
　NALL 271 (43.8) 135 (21.8) 65 (10.5) 12 (1.9) 1 (0.2) 484 (78.2)
　Benign 17 (2.7) 45 (7.3) 11 (1.8)  1 (0.2) 1 (0.2)  75 (12.1)
　Indeterminate   9 (1.5) 18 (2.9) 20 (3.2)  3 (0.5) 0 (0.0) 50 (8.1)
　Metastasis   0 (0.0)   0 (0.0)  0 (0.0)  8 (1.3) 0 (0.0)   8 (1.3)
　Lung cancer   0 (0.0)   0 (0.0)  0 (0.0)  2 (0.3) 0 (0.0)   2 (0.3)
Total 297 (48.0) 198 (32.0) 96 (15.5) 26 (4.2) 2 (0.3)  619 (100.0)
Values are presented as number (%).
CT, computed tomography; NALL, no active lung lesion; CXR, chest radiography; AP-CT, abdominopelvic CT.
Table 2. Distribution of pulmonary metastases
Upper Lower Both Total
Right 3 (9.7)   6 (19.4) 1 (3.2) 10 (32.3)
Left 2 (6.4) 3 (9.7) 0 (0.0)  5 (16.1)
Bilateral 0 (0.0) 1 (3.2) 15 (48.4) 16 (51.6)
Total 5 (16.1) 10 (32.3) 16 (51.6) 31 (100.0)
Values are presented as number (%).
Fig. 4.  Treatment of the pulmonary metastases. VATS, video- 
assisted thoracoscopic surgery.
(2.9%) of the 26 patients with pulmonary metastases un-
derwent a change in treatment strategy due to the pre-
operative detection of a pulmonary metastasis according 
to changes in the guidelines. Among these patients, 23 
(3.7%) had isolated pulmonary metastases, 2 had simulta-
neous hepatic metastases, and 1 had peritoneal seeding.
In the chest CT group, four patients (0.6%) had in-
cidental detection of combined lesions (two lung cancers, 
one thyroid cancer, and one thymoma) and they received 
curative surgery.
Five patients were diagnosed with pulmonary meta-
stases on the follow-up chest CT. The preoperative chest 
CT of four of the five patients revealed benign nodules, 
and one of them was diagnosed with indeterminate 
nodules. The preoperative AP-CT showed that two of the 
five patients were normal, and three were diagnosed with 
benign nodules. All were normal on CXR.
Finally, 31 patients (5.0%) were diagnosed with pulmo-
nary metastasis. Five of these patients (16.1%) had a dis-
tribution in the upper hilar area, 10 (32.3%) in the lower hi-
lar area, and 16 (51.6%) in both areas (Table 2).
The sensitivity of the chest CT group was 83.9% and that 
of the CXR group was 29.0% (P ＜ 0.0001). The negative 
predictive value for the detection of pulmonary meta-
stases was 99.0% in the chest CT group and 91.4% in the 
CXR group (P = 0.0002). The accuracy was 99.0% in the 
chest CT group and 91.5% in the CXR group (P = 0.0003). 
There was no different value of the specificity and positive 
predictive value between the two groups.
DISCUSSION
The lung is one of the most frequent sites for CRC meta-
stasis, which affects about 10% of all patients [1]. Isolated 
pulmonary metastasis occurs in only 1% of patients and is 
usually associated with another systemic metastasis such 
as the liver, brain, or bone [5,13]. Pulmonary metastases 
are usually unresectable due to multiple lesions but after a 
complete resection of pulmonary metastasis from CRC, 
there are significant improvements in survival and in Routine chest CT as a preoperative work-up for primary colorectal cancer
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Table 3. Pulmonary metastases according to primary tumor 
location
Colon Rectum Total
Pulmonary metastases (−) 322 (52.0) 266 (43.0) 588 (95.0)
Pulmonary metastases (＋) 12 (1.9) 19 (3.1) 31 (5.0)
Total 334 (53.9) 285 (46.1) 619 (100.0)
Values are presented as number (%).
P-value is 0.081.
long-term survivors; multiple series have reported 5-year 
survival rates of 30.5 to 55% [14-19]. Therefore, it is im-
portant to detect pulmonary metastases from primary 
CRC to identify treatment strategies for patients [20,21]. 
Ike et al. [22] reported that screening with chest CT and 
pulmonary resection improves the prognosis of pulmo-
nary metastasis from CRC, whereas Schoemaker et al. [23] 
reported that there was no benefit of a yearly colonoscopy, 
liver CT, or CXR for prognosis after curative resection of 
CRC. Thus, early detection of pulmonary metastasis is im-
portant to improve the prognosis of resectable CRC with 
pulmonary metastases. Generally, the detection rate for 
plain chest radiography is lower than for CT, so AP-CT 
with a hilar extension could be helpful in detecting periph-
eral, especially lower, multiple metastatic nodules [24]. 
Currently, preoperative pulmonary staging for CRC is 
conducted by CXR, but CXR only identifies 1.8-12.0% of 
patients with resectable pulmonary metastases [25]. In this 
study, CXR detected only 9.7% (3/31) of pulmonary meta-
static nodules. According to the NCCN guidelines v. 1. 
2007, chest CT is recommended instead of CXR for pre-
operative CRC staging [7,8]. A chest CT scan is 51 to 73% 
more sensitive than CXR for the detection of pulmonary 
metastases [26]. The specificity of chest CT is also superior 
to that of CXR and has been reported to be about 74% accu-
rate [27].
In this study we investigated the role of chest CT and 
compared it with AP-CT with a hilar extension and CXR, 
which were used previously for preoperative staging of 
primary CRC. The accuracy of the chest CT (99%) was bet-
ter than AP-CT with hilar extension and CXR (91.5%) in 
detecting pulmonary metastases. 
Pulmonary metastases were mainly hematogeneous 
spreading, multiple nodules, with peripheral and lower 
hilar locations, so they could be detected by AP-CT with a 
hilar extension [28,29]. Also in this study, 26 patients 
(83.9%) had metastatic lesions in the lower hilar or both 
lung fields. But the pulmonary metastases in the upper hi-
lar area could not be detected with CXR and AP-CT with a 
hilar extension (in our study, about 16.1% were detected); 
thus, chest CT would be helpful for these patients. 
Although the AP-CT scan extended to the hilar, we did not 
find pulmonary metastases in 12 patients (38.7%). The rea-
sons for the different detection rates between AP-CT and 
chest CT were: 1) AP-CT with a hilar extension can’t detect 
metastases if the lesions are located in the upper hilar area; 
2) the thickness of the slice is different between AP-CT and 
chest CT (5.0 mm vs. 2.5 mm); and 3) differences in the 
imaging method, i.e., AP-CT is conducted in a full expira-
tion state, whereas chest CT is conducted in a full inspira-
tion state, so if the metastasis is located in basal lung, the 
lung would be collapsed, and small-sized metastatic nod-
ules wouldn’t be detected by AP-CT.
In addition to chest CT’s higher detection rate for pul-
monary metastasis than the previous method, it provided 
more information as a preoperative work-up. For exam-
ple, we were able to find other meaningful lesions such as 
lung cancer, thymoma, and thyroid cancer. A preoperative 
chest CT also could be used as a baseline study for fol-
low-up of presumed benign and indeterminate lesions. In 
this study, five patients (four benign and one in-
determinate) were diagnosed with pulmonary metastasis 
on the follow-up chest CT at 3 or 6 months due to a change 
in shape or increase in nodule size. 
Pulmonary metastases were more common with rectal 
cancer than with colon cancer. In this study, 31 patients 
(5.0%) had pulmonary metastases and, among them, 12 
(1.9%) had colon cancer and 19 (3.1%) had rectal cancer, al-
though the differences were not significant (P = 0.081, 
Table 3). 
Although the detection rate for pulmonary metastasis 
using a chest CT was higher, too many insignificant lesions 
were detected on pre-operative chest CT (52.0% vs. 21.8%), 
and they could be confusing when defining a proper treat-
ment strategy. Although we didn’t investigate the hazard-
ous effect of radiation and cost effectiveness, the patients 
who had benign and indeterminate lesions on pre-Yong Kwon Cho, et al.
332 thesurgery.or.kr
operative chest CT were checked by positron emission to-
mography or follow-up chest CT at short-term intervals.
In conclusion, although this study was limited by a 
short-term follow-up, our results suggest that the new 
guidelines, which include chest CT as a preoperative pul-
monary work-up, are better than the previous guidelines, 
which included AP-CT with hilar extension and CXR for 
CRC. If benign or indeterminate lesions were detected on 
pre-operative chest CT, they should not be ignored and 
should be followed up with chest CT during short-term 
intervals. In these cases, preoperative chest CT could be 
used as a baseline study for follow-up. However, the large 
number of insignificant lesions detected on pre-operative 
chest CT may confuse the treatment strategy.
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